Chlofazimine Other names: Clofazimine

Chemical formula: C₂₇H₂₂Cl₂N₄  Molecular mass: 473.396 g/mol  PubChem compound: 2794

Active ingredient description

Clofazimine is an antimycobacterial drug. Clofazimine exerts a slow bactericidal effect on Mycobacterium leprae (Hansen’s bacillus). Clofazimine inhibits mycobacterial growth and binds preferentially to mycobacterial DNA.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
J04BA01 Clofazimine J Antiinfectives for systemic use → J04 Antimycobacterials → J04B Drugs for treatment of lepra → J04BA Drugs for treatment of lepra
Discover more medicines within J04BA01

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 2030-63-9
DrugBank Drug: DB00845
KEGG Drug: D00278
PubChem Compound: 2794
RxNorm Ingredient: 2592
SNOMED-CT Concept: 387410004
Clofazimine (substance)
UNII Identifier: D959AE5USF
CLOFAZIMINE

Medicines

Chlofazimine is an active ingredient of these brands:

Estonia (EE)

France (FR)

Japan (JP)

Lithuania (LT)

Malta (MT)

South Africa (ZA)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈